Combined synopsis and solicitation
3D Microscopy, Artificial Intelligence-based Quantification and Modeling for Non-Clinical Evaluation and Regulatory Support of Complex Drug Products
FDA-75F40124Q00047
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
May 23, 2024 at 2:30 PM EDT
Closed 893 days ago. Posted May 8, 2024, first published May 8, 2024. Scheduled to archive June 7, 2024.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2024
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Quantitative Analysis of Longitudinal MR Images
National Institutes of Health, National Institutes of Health Olao
Sources soughtNAICS 541714Bethesda, MD75N98027R00005Closes in 7 daysNov 9 - RFI Lupus Research Program (LRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027LRPCloses in 14 daysNov 16 - RFI Alzheimer’s Research Program (AZRP) Public
Defense Health Agency (Dha), Defense Health Agency
Sources soughtNAICS 541714Frederick, MDHT9427RFI2027AZRPCloses in 32 daysDec 4
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
This is a combined synopsis/solicitation for commercial services prepared in accordance with the Federal Acquisition Regulation (FAR) format in 15.204-1, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
This solicitation authorized under FAR Part 12 “Acquisition of Commercial Products and Commercial Services” and 13.5 “Simplified Procedures for Certain Commercial Products and Commercial Services” is for the award of one (1) Indefinity Delivery Indefinite Quantity (IDIQ) contract. The solicitation number is FDA-75F40124Q00047. This solicitation is issued as a Request for Quote (RFQ). This is a Full and Open Competition.
The solicitation document and incorporated provisions and clauses in effect through the Federal Acquisition Circular 2024-04, effective 01 May 2024. FAR and HHSAR provisions and clauses referenced in this RFQ can be found on the following website: https://www.acquisition.gov/browse/index/far
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Lillian Lamblillian.lamb@fda.hhs.gov3017961316